The involvement of protein kinase C-βII in glucose-induced rat vascular smooth muscle cell proliferation

Journal of Anti-Aging Medicine

Volumn 1, Issue 3, 1998, Pages 207-218

  Yamamoto, Mayumi ^a   Patel, Niketa A ^a   Cooper, Denise R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344441638     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.1.1998.1.207     Document Type: Article

References (70)

1. Manton KG, Stallard E, Corder LS: The dynamics of dimensions of age-related disability 1982 to 1994 in the US elderly population. J Gerontol 1998;53A:B59-B70.
2. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature (London) 1993;362:801-809.
3. Schwartz SM, Campbell GR, Campbell JH: Replication of smooth muscle cells in vascular disease. Circ Res 1986;58:427-444.
4. Garcia MJ, McNamara PM, Gordon T, et al.: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23:105-111.
5. Kleinman JC, Donahue RP, Harris MI, et al.: Mortality among diabetics in a national sample. Am J Epidemiol 1988;128:389-401.
6. Stamler J, Vaccaro O, Neaton JD, et al.: For the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
7. Melton LJ 3rd, Macken KM, Palumbo PJ, et al.: Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 1980;3:650-654.
8. Abbott RD, Donahue RP, MacMahon SW, et al.: Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 1987;257:949-952.
9. Santen RJ, Willis, PW 3rd, Fajans SS, et al.: Atherosclerosis in diabetes mellitus. Arch Intern Med 1972; 130:833-843.
10. West KM, Ahuja MMS, Bennett PH, et al.: The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983;6:361-369.
11. Wilson PWF, Cupples LA, Kannel WB: Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 1991;121:586-590.
12. Natarajan R, Gonzales N, Xu L, et al.: Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 1992;187:552-560.
13. Thyberg J, Hedin U, Sjölund M, et al.: Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriolosclerosis 1990;10:966-990.
14. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-613.
15. Lee MW, Severson DL: Signal transduction in vascular smooth muscle: Diacylglycerol second messengers and PKC action. Am J Physiol 1994;267:C659-678.
16. Kariya K, Kawahara Y, Tsuda T, et al.: Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis 1987;63:251-255.
17. Kariya K, Fukumoto Y, Tsuda T, et al.: Antiproliferative action of protein kinase C in cultured rabbit aortic smooth muscle cells. Exp Cell Res 1987;173:504-514.
18. Weiss RH, Huang C-L, Ives HE: Sphingosine reverses growth inhibition caused by activation of protein kinase C in vascular smooth muscle cells. J Cell Physiol 1991;149:307-312.
19. Huang C-L and Ives HE: Growth inhibition by protein kinase C late in mitogenesis. Nature (London) 1987;29:849-850.
20. Kariya K, Fukumoto Y, Tsuda T, et al.: Inhibition of DNA synthesis by phorbol esters through protein kinase C in cultured rabbit aortic smooth muscle cells. FEBS Lett 1987;217:69-73.
21. Sasaguri T, Ishida A, Kosaka C, et al: Phorbol ester inhibits the phosphorylation of the retinoblastoma protein without suppressing cyclin D-associated kinase in vascular smooth muscle cells. J Biol Chem 1996;271:8345-8351.
22. 1/S inhibition. Exp Cell Res 1993;208:311-320.
23. Nishizuka Y: The molecular heterogenicity of protein kinase C and its implications for cellular regulation. Nature (London) 1988;34:661-665.
24. Stabel S, Parker PJ: Protein kinase C. Pharmacol Ther 1991;1:71-95.
25. Johannes F-J, Prestle J, Eis S, et al.: PKCu is a novel, atypical member of the protein kinase C family. J Biol Biochem 1994;269:6140-6148.
26. Nishizuka Y: Studies and perspectives of protein kinase C. Science 1986;233:305-312.
27. Rozengurt E: Early signals in the mitogenic response. Science 1986;234:161-166.
28. Dicker P, Rozengurt E: Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism. Nature (London) 1980;287:607-612.
29. 2+-sensitive phospholipid-dependent protein kinase. Proc Natl Acad Sci USA 1984;1:5748-5752.
30. Rodriguez-Pena A, Rozengurt E: Serum, like phorbol esters, rapidly activates protein kinase C in intact quiescent fibroblasts. EMBO J 1985;4:71-76.
31. Cooper DR, Khalakdina A, Watson JE: Chronic effects of glucose on insulin signaling in A-10 vascular smooth muscle cells. Arch Biochem Biophys 1993;302: 490-498.
32. Kimes BW, Brandt BL: Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 1976;98:349-366.
33. Ono Y, Kikkawa U, Ogita K, Fuji, T., et al.: Expression and properties of two types of protein kinase C: Alternative splicing from a single gene. Science 1987;236:1116-1120.
34. Ono Y, Kurokawa T, Fujii T, et al.: Two types of complementary DNAs of rat brain protein kinase C. Heterogeneity determined by alternative splicing. FEBS Lett 1986;206:347-352.
35. 0 phase, in vascular smooth muscle cells. Biochem Biophys Res Commun 1995;211:619-626.
36. Draznin B, Leitner JW, Sussman KE, et al.: Insulin and glucose modulate protein kinase C activity in rat adipocytes. Biochem Biophys Res Commun 1988;156: 570-575.
37. Ishizuka T, Hoffman J, Cooper DR, et al.: Glucose-induced synthesis of diacylglycerol de novo is associated with translocation (activation) of protein kinase C in rat adipocytes. FEBS Lett 1989;249:234-238.
38. Haller H, Baur E, Quass P, et al: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 1995;47:1057-1067.
39. Willians B, Schrier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 1992;41: 1464-1472.
40. Lee T-S, Saltsman KA, Ohashi H, et al.: Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 1989;86:5141-5145.
41. Xia P, Inoguchi T, Kern TS, et al.: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994;40:1122-1129.
42. Inoguchi T, Battan R, Handler E, et al.: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89: 11059-11063.
43. Housey GM, Johnson MD, Hsiao WLW, et al.: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 1988;2:343-354.
44. Guadagno SN, Borner C, Weinstein IB: Altered regulation of a major substrate of protein kinase C in rat six fibroblasts overproducing PKCβI. J Biol Chem 1992;267:2697-2707.
45. Kahn SM, O'Driscoll KR, Jiang W, et al.: Suppression of mitogenic activity by stable expression of the regulatory domain of PKCβ. Carcinogenesis 1994;15:2919-2925.
46. Yamamoto M, Acevedo-Duncan M, Chalfant CE, et al.: Regulation of protein kinase C in vascular smooth muscle cells: Involvement of βI and βII isozyme in cell proliferation. Exp Cell Res 1998;240:349-358.
47. Mischak H, Pierce JH, Goodnight J, et al.: Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and -δ and not by protein kinase C-βII, -∈, -ζ, and -η. J Biol Chem 1993;268:20110-20115.
48. Ross R, Nist C, Kariya B, et al.: Physiological quiescence in plasma-derived serum: Influence of platelet derived growth factor on cell growth in culture. J Cell Physiol 1978;97:497-508.
49. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
50. Laemmuli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970;227:680-685.
51. Patel NA, Chalfant CE, Yamamoto M, et al.: Multilevel regulation of protein kinase Cβ isozyme expression by glucose in vascular smooth muscle cells; FASEB J 1998 (in press).
52. Chalfant CE, Ohno S, Konno Y, et al.: A carboxy-terminal deletion mutant of protein kinase CβII inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells. Mol Endocrinol 1996;10:1273-1281.
53. Meyer T, Regenass U, Fabbro D, et al.: A derivative of staurosporine (CG41251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in in vivo anti-tumor activity. Int J Cancer 1989;43:851-856.
54. Kosaka C, Sasaguri T, Masuda J, et al.: Protein kinase C-mediated inhibition of cyclin A expression in human vascular endothelial cells. Biochem Biophys Res Comm 1993;193:991-998.
55. Zhou W, Takuwa N, Kumada M, et al.: Protein kinase C mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinase in human vascular endothelial cells. J Biol Chem 1993;268:23041-23048.
56. Zhou W, Takuwa N, Kumada M, et al.: E2F1, B-myb, and selective members of cyclin/CDK subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells. Biochem Biophys Res Commun 1994;199:191-198.
57. Gabbay RA, Siconolfi-Baez L, Lebovitz HE: Calcium-dependent protein kinase activity is decreased in diabetic rat sciatic nerve. Endocrinology 1990;127:1194-1198.
58. Ishizuka T, Yamamoto M, Kajita K, et al: Differential effect of aging on protein kinase C activity in rat adipocytes and soleus muscle. Metabolism 1993;42: 420-425.
59. Cooper DR, Watson JE, Dao ML: Decreased expression of protein kinase C α, β, and ∈ in soleus muscle of Zucker obese (fa/fa) rats. Endocrinology 1993;133: 2241-2247.
60. Patel NA, Yamamoto M, Chalfant CE, et al.: Multilevel regulation of PKCβ gene expression by glucose in A10 vascular smooth muscle cells. Program of the 17th Annual Meeting of the American Society of Biochemistry and Molecular Biology, San Francisco, 1997. Abstract pA1185.
61. Patel NA, Chalfant CE, Yamamoto M, et al.: Multilevel regulation of PKCβ gene expression by glucose in vascular smooth muscle cells [Abstract]. Program of the 80th Annual Meeting of the Endocrine Society, Chicago, 1998.
62. Divecha N, Banfić H, Irvine RF: The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-1) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J 1991;10:3207-3214.
63. Martelli AM, Neri LM, Gilmour RS, et al.: Temporal changes in intracellular distribution of protein kinase C in Swiss 3T3 cells during mitogenic stimulation with insulin-like growth factor I and bombesin: Translocation to the nucleus follows rapid changes in nuclear polyphosphoinositides. Biochem Biophys Res Commun 1991;177:480-487.
64. Divecha N, Banfić H, Irvine RF: Inositides and the nucleus and inositides in the nucleus. Cell 1993;74: 405-407.
65. Takagi Y, Hirata Y, Takata S, et al: Effects of protein kinase inhibitors on growth factor-stimulated DNA synthesis in cultured rat vascular smooth muscle cells. Atherosclerosis 1988;74:227-230.
66. Matsumoto H, Sasaki Y: Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. Biochem Biophys Res Commun 1989;158:105-109.
67. Ohmi K, Yamashita S, Nonomura Y: Effect of K252a, a protein kinase inhibitor, on the proliferation of vascular smooth muscle cells. Biochem Biophys Res Commun 1990;173:976-981.
68. Newby AC, Lim K, Evans MA, et al: Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C. Br J Pharmacol 1995;114:1652-1656.
69. Ishii H, Jirousek MR, Koya D, et al.: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 1996;272:728-731.
70. Babazono T, Kapor-Drezgic J, Dlugosz JA, et al.: Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 1998;47:668-676.